Stock Fundamentals

Company Information

Company Name
Amgen Inc
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
ISIN: US0311621009
CIK: 0000318154
CUSIP: 031162100
Currency: USD
Full Time Employees: 31,500
Phone: 805 447 1000
Fiscal Year End: December
IPO Date: Jun 17, 1983
Description:

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

Address:

One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799

Directors & Officers

Name Title Year Born
Mr. Robert A. Bradway Chairman & CEO 1963
Mr. Peter H. Griffith Executive VP & CFO 1959
Dr. David M. Reese M.D. Executive VP & CTO 1963
Mr. Murdo Gordon EVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy 1967
Dr. James E. Bradner M.D. EVP of Research & Development, Artificial Intelligence and Data 1972
Mr. Esteban Santos Executive Vice President of Operations 1968
Mr. Matthew C. Busch Chief Accounting Officer & VP of Finance 1975
Mr. Scott Skellenger Senior VP & Chief Information Officer NA
Mr. Howard Y. Chang M.D., Ph.D. Senior VP of Global Research & Chief Scientific Officer NA
Casey Capparelli Executive Director of Investor Relations NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 30, 2026 Ro Khanna N/A Sale N/A $349.00 N/A
Mar 24, 2026 Maria Elvira Salazar N/A Purchase N/A $348.43 N/A
Feb 26, 2026 David Taylor N/A Sale N/A $379.33 N/A
Feb 24, 2026 Ro Khanna N/A Purchase N/A $382.87 N/A
Jan 29, 2026 David Taylor N/A Sale N/A $342.94 N/A
Jan 23, 2026 Ro Khanna N/A Sale N/A $344.75 N/A
Jan 16, 2026 David Taylor N/A Purchase N/A $330.41 N/A
Dec 03, 2025 David Taylor N/A Sale N/A $345.42 N/A
Nov 20, 2025 Nancy A Grygiel N/A Sale 3.14K $337.26 $1.06M
Nov 12, 2025 Rachna Khosla N/A Sale 890.00 $336.24 $299.25K
Nov 12, 2025 Murdo Gordon N/A Sale 6.88K $336.83 $2.32M
Oct 24, 2025 Marjorie Taylor Greene N/A Purchase N/A $291.76 N/A
Sep 29, 2025 Ro Khanna N/A Sale N/A $273.97 N/A
Sep 25, 2025 Lisa C. McClain N/A Sale N/A $271.18 N/A
Sep 11, 2025 Marjorie Taylor Greene N/A Purchase N/A $282.73 N/A
Sep 04, 2025 Sheldon Whitehouse N/A Sale N/A $280.10 N/A
Aug 20, 2025 Nancy A Grygiel N/A Sale 1.27K $296.99 $376.29K
Jun 24, 2025 Lisa C. McClain N/A Purchase N/A $277.49 N/A
Jun 06, 2025 Cliff Bentz N/A Purchase N/A $290.33 N/A
Jun 05, 2025 Rachna Khosla N/A Sale 1.50K $289.68 $434.52K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 54.84M Dec 31, 2025 10.16% $0.26 1.79%
BlackRock Inc 47.10M Mar 31, 2026 8.73% $0.29 -0.62%
Vanguard Capital Management, LLC 35.01M Mar 31, 2026 6.49% $0.30 0.00%
State Street Corp 30.55M Mar 31, 2026 5.66% $0.37 -0.14%
Capital World Investors 29.29M Mar 31, 2026 5.43% $1.41 26.80%
Morgan Stanley - Brokerage Accounts 15.84M Mar 31, 2026 2.93% $0.34 0.58%
Geode Capital Management, LLC 15.43M Mar 31, 2026 2.86% $0.34 7.88%
Vanguard Portfolio Management, LLC 14.62M Mar 31, 2026 2.71% $0.27 0.00%
Charles Schwab Investment Management Inc 12.77M Mar 31, 2026 2.37% $0.69 8.15%
PRIMECAP Management Company 8.87M Mar 31, 2026 1.64% $2.46 -0.35%
JPMorgan Chase & Co 7.28M Mar 31, 2026 1.35% $0.16 217.31%
Capital Research & Mgmt Co - Division 3 7.12M Mar 31, 2026 1.32% $0.59 -60.84%
Wells Fargo & Co 7.09M Mar 31, 2026 1.31% $0.47 -0.32%
Capital Research Global Investors 6.96M Mar 31, 2026 1.29% $0.38 49.64%
NORGES BANK 6.61M Dec 31, 2025 1.23% $0.23 10.96%
Northern Trust Corp 6.22M Mar 31, 2026 1.15% $0.29 0.59%
Bank of America Corp 5.12M Mar 31, 2026 0.95% $0.13 -7.52%
UBS Asset Mgmt Americas Inc 4.78M Mar 31, 2026 0.89% $0.35 3.93%
Amvescap Plc. 4.57M Mar 31, 2026 0.85% $0.25 -4.53%
Royal Bank of Canada 4.47M Mar 31, 2026 0.83% $0.28 -4.96%

Shares Statistics

Shares Outstanding: 539.71M
Shares Float: 538.23M
% Insiders: 21.80%
% Institutions: 8,542.80%
Short % Float: 2.20%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 17.18M 3.18% ▲ 0.30% Apr 30, 2026
2 Vanguard 500 Index Investor 13.96M 2.59% ▲ 1.83% Apr 30, 2026
3 Invesco QQQ Trust 11.68M 2.16% ▲ 0.47% May 29, 2026
4 Schwab US Dividend Equity ETF™ 9.79M 1.81% ▲ 0.19% May 30, 2026
5 Capital Group Wash Mutual Invtrs Comp 8.63M 1.60% ▼ 17.05% Mar 31, 2026
6 American Funds Washington Mutual A 8.63M 1.60% ▼ 17.05% Mar 31, 2026
7 American Funds Income Fund of Amer A 7.61M 1.41% ▲ 69.01% Mar 31, 2026
8 iShares Core S&P 500 ETF 7.09M 1.31% ▲ 0.31% May 29, 2026
9 American Funds American Balanced A 6.94M 1.29% ▲ 16.90% Mar 31, 2026
10 Fidelity 500 Index 6.90M 1.28% ▲ 0.35% Apr 30, 2026

Valuation Metrics

Enterprise Value: $236.99B
Trailing P/E: 24.68
Forward P/E: 15.97

Financial Highlights

Market Cap: $191.70B
EBITDA: $16.92B
P/E Ratio: $24.68
PEG Ratio: $2.35
Book Value: $17.03
Dividend/Share: $9.66
Dividend Yield: 2.73%
Earnings/Share: $14.39
Profit Margin: 20.96%
Operating Margin: 33.80%
ROA (TTM): 8.35%
ROE (TTM): 101.32%
Revenue (TTM): $37.22B
Revenue/Share (TTM): $69.12
Earnings Growth (YOY): 4.40%
Revenue Growth (YOY): 5.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.14x 6.31x 0.90x 3.88x 3.23x
2024-12-31 1.26x 10.23x 0.94x 2.30x 4.50x
2023-12-31 1.65x 10.37x 0.94x 2.75x 8.18x
2022-12-31 1.41x 10.64x 0.94x 6.80x 3.20x
2021-12-31 1.59x 4.97x 0.89x 6.38x 2.95x
2020-12-31 1.81x 3.51x 0.85x 7.24x 2.54x
2019-12-31 1.44x 3.09x 0.84x 7.51x 2.37x
2018-12-31 2.79x 2.71x 0.81x 7.37x 2.63x
2017-12-31 5.49x 1.40x 0.68x 7.65x 2.75x
2016-12-31 4.11x 1.16x 0.62x 7.77x 2.76x
2015-12-31 4.45x 1.12x 0.61x 7.74x 2.82x
2014-12-31 4.95x 1.19x 0.63x 5.78x 3.51x
2013-12-31 3.44x 1.45x 0.67x 5.74x 4.24x
2012-12-31 3.81x 1.39x 0.65x 5.30x 3.71x
2011-12-31 4.80x 1.13x 0.61x 7.07x 3.68x
2010-12-31 3.52x 0.56x 0.45x 9.18x 1.93x
2009-12-31 4.89x 0.47x 0.43x 9.53x 1.55x
2008-12-31 3.12x 0.50x 0.44x 9.46x 1.53x
2007-12-31 2.11x 0.63x 0.48x 1.86x 1.87x
2006-12-31 1.67x 0.48x 0.44x 1.68x 1.49x
2005-12-31 2.57x 0.19x 0.30x 167.17x 0.70x
2004-12-31 2.21x 0.26x 0.33x 3.16x 1.10x
2003-12-31 3.01x 0.16x 0.26x 30.42x 0.82x
2002-12-31 4.19x 0.17x 0.25x -0.06x 1.19x
2001-12-31 3.85x 0.06x 0.19x 7.58x 0.18x
2000-12-31 3.41x 0.07x 0.20x 2.84x 0.20x
1999-12-31 2.49x 0.03x 0.26x 3.24x 0.07x
1998-12-31 2.10x 0.04x 0.30x 5.04x 0.08x
1997-12-31 2.08x 0.01x 0.31x 6.94x 0.03x
1996-12-31 2.34x 0.06x 0.31x 9.27x 0.12x
1995-12-31 2.49x 0.04x 0.31x 9.22x 0.08x
1994-12-31 2.08x 0.08x 0.36x 3.35x 0.13x
1993-12-31 2.56x 0.09x 0.34x 5.66x 0.18x
1992-12-31 2.81x 0.00x 0.32x 3.83x 0.00x
1991-12-31 2.00x 0.00x 0.39x 1.75x 0.01x
1990-12-31 3.17x 0.00x 0.23x N/A 0.02x
1989-12-31 3.30x 0.01x 0.39x 7.46x 0.03x
1988-12-31 6.48x 0.01x 0.22x -1.02x 0.66x
1987-12-31 9.30x 0.01x 0.15x -0.36x -1.33x
1986-12-31 11.22x 0.01x 0.13x -0.23x 0.42x
1985-12-31 14.85x 0.01x 0.14x -0.60x 0.31x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about AMGN.US!